Could a depression drug ease arthritis pain? new study investigates
NCT ID NCT07497282
First seen Apr 04, 2026 · Last updated Apr 28, 2026 · Updated 3 times
Summary
This study tests whether adding venlafaxine, an antidepressant, to standard rheumatoid arthritis (RA) treatment can reduce joint inflammation and pain. About 70 adults with moderate to severe RA who are already on stable medication will receive either venlafaxine or a placebo for several months. The goal is to see if this drug can improve disease control without the high costs and risks of stronger immune-suppressing drugs.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for RHEUMATOID ARTHRITIS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.